|
PF-30519 |
LIBRAMUCIL 0.1 g /5 mL polvo para suspension oral |
2008-05-21 |
|
Grunenthal Ecuatoriana Cia. Ltda |
Ecuador
|
Bayer S.A. |
Agencias J.i. Cohen |
Lanquetin S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30520 |
LIBRANIDAZOL 500 mg tabletas recubiertas |
2008-05-21 |
|
Grunenthal Ecuatoriana Cia. Ltda |
Ecuador
|
Bayer S.A. |
Agencias J.i. Cohen |
Lanquetin S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30521 |
LIBRANIDAZOL 1 g tabletas recubiertas |
2008-05-21 |
|
Grunenthal Ecuatoriana Cia. Ltda |
Ecuador
|
Bayer S.A. |
Agencias J.i. Cohen |
Lanquetin S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30551 |
LIBRAFLAM 50 mg grageas simples |
2008-05-23 |
|
Grunenthal Ecuatoriana Cia. Ltda |
Ecuador
|
Bayer S.A. |
Agencias J.i. Cohen |
Lanquetin S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30824 |
DOLRAD 500 mg Comprimidos |
2008-06-23 |
|
Grunenthal Ecuatoriana Cia. Ltda |
Ecuador
|
Agencias J. I. Cohen |
Bayer S.A. |
Lanquetin S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31156 |
DOLO-APRANAX Tabletas |
2028-10-04 |
|
Grunenthal Ecuatoriana Cia. Ltda |
Ecuador
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Resco |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31157 |
DOLO-APRANAX Suspension Oral |
2013-08-13 |
|
Grunenthal Ecuatoriana Cia. Ltda |
Ecuador
|
Bayer S.A. |
Agencias J.i. Cohen |
Lanquetin S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31544 |
YXALAN 250 mg/5mL, suspensión oral |
2013-11-06 |
|
Grunenthal Ecuatoriana Cia. Ltda |
Ecuador
|
Agencias J.I. Cohen |
Lanquetin S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-13363 |
FEMSTAT 100 mg Ovulos Vaginales |
2028-12-05 |
|
Grunenthal Ecuatoriana Cia. Ltda |
Ecuador
|
J.I.Cohen, S.A. |
Agencias J.I. Cohen |
Resco |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-13365 |
TOPSYM POLYOL 0.05 % Crema |
2009-02-09 |
|
Grunenthal Ecuatoriana Cia. Ltda |
Ecuador
|
Bodega Farmacéutica, S.A. |
Bayer S.A. |
Agencias J.i. Cohen |
Lanquetin S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|